Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 3,980 | 3,508 | 2,448 | 2,602 | 2,587 |
| Gross Profit | 3,980 | 3,508 | 2,448 | 2,602 | 2,587 |
| Operating Expenses | 1,913 | 1,463 | 1,669 | 1,554 | 1,338 |
| Operating Income | 2,067 | 2,045 | 780 | 1,048 | 1,249 |
| Other Income | 6 | 7 | 8 | 10 | 10 |
| Pre-tax Income | 2,073 | 2,052 | 788 | 1,057 | 1,258 |
| Income Tax | 720 | 951 | 317 | 391 | 516 |
| Net Income Continuous | 1,353 | 1,101 | 471 | 667 | 742 |
| Net Income | $1,353 | $1,101 | $471 | $667 | $742 |
| EPS Basic Total Ops | 0.21 | 0.17 | 0.07 | 0.11 | 0.12 |
| EPS Basic Continuous Ops | 0.21 | 0.17 | 0.07 | 0.11 | 0.12 |
| EPS Diluted Total Ops | 0.19 | 0.15 | 0.07 | 0.10 | 0.11 |
| EPS Diluted Continuous Ops | 0.19 | 0.16 | 0.07 | 0.10 | 0.11 |
| EBITDA(a) | $2,083 | $1,912 | $794 | $1,064 | $1,261 |